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Background: Hemangioma and vascular malformation are benign vascular lesions that often occur in cephalic
and cervical region. Currently, surgical resection, laser therapy, angiographic embolization, use of steroids, and
sclerotherapy are used as treatments.
Case presentation: This study reports three cases of benign vascular lesions that are remarkably treated by
sodium tetradecyl sulfate (STS) injection, of which occurred in oral cavity and around the mouth. Three
percent of STS was diluted with 0.9 % of normal saline, and it was injected to the lesion site at least once.
The result of treatment was evaluated based on clinical findings.
Conclusion: Surgical treatment of hemangioma and vascular malformation occurred in oral cavity is not normally
used because of esthetic issues and potential hemorrhage. On the other hand, sclerotherapy using STS is an
effective therapy compare to surgical treatment. Despite the number of STS injection was different for each
patient, all three patients had reached satisfactory level through the treatment with gradual diminution of lesions.
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Hemangioma and vascular malformation are common
benign lesions of vessel that often occur in cephalic and
cervical regions. The comprehensive term “hemangioma”
was classified into two (i.e., hemangioma and vascular
malformation) by Mulliken and Glowacki in 1982 [1].
Hemangiomas are endothelial tumors that exhibit
endothelial proliferation with rapid growth and gradual
regression. They are classified into superficial, deep, and
compound hemangioma according to the depth of the
lesion. These lesions are more common in females.
Craniofacial region is the most affected site (60 %) [2].
Hemangioma in oral cavity may include pain, hemorrhage,
secondary infection, ulcerative lesion, and tissue trans-
formation [3–5].
Vascular malformations are structural abnormalities
without endothelial cell proliferation. Vascular malfor-
mations can be sub-divided into two types (i.e., low and* Correspondence: omfskso@chonbuk.ac.kr
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the Creative Commons license, and indicate ifhigh flow) due to hemodynamic features [6]. Low-flow
vascular malformations include capillary, venous, and
lymphatic lesions depending on the type of vessels.
High-flow vascular malformations include arterial
malformation [2]. The most common regions where it
occurs in the oral cavity are two thirds of the anterior
tongue, palate, gingiva, and buccal mucosa [7]. It gener-
ally appears at birth and increases its size as it grows.
Functional difficulty may occur such as swallowing,
maintaining the respiratory tract, and obstructive sleep
apnea when vascular lesion involves deep tissue such as
muscle and bone [8]. The lesions on the face cause
esthetic problems, even during regression state.
Various methods for the treatment of hemangioma
and vascular malformations have been introduced.
There are continuous observation, radiation therapy,
laser therapy, steroid treatment, sclerotherapy, and
surgical resection.
We report three cases of benign vascular lesions that
are remarkably treated by sodium tetradecyl sulfate
(STS) injection which occurred in oral cavity esthetically
and functionally.is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
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Case 1
A 27-year-old woman with chief complaint of repetitive
swelling and bruise on the right buccal mucosa visited
the maxillofacial department. The patient has recognized
the lesion for about 4 years. During oral examination, a
painless bluish red lesion with the size of 3 × 2 × 0.5 cm
was observed at the right buccal mucosa. Bluish dome-
shaped lesion was located at the center and red region
scattered around the buccal mucosa (Fig. 1a). On extra-
oral examination, slight facial swelling was observed.
The patient complained tingling sensation rather than
pain. Panoramic radiograph result was nothing special.
T2-weighted magnetic resonance imaging presented
mass lesion with ill-defined margin in the right lower
subcutaneous area. Incisional biopsy revealed that the
lesion was cavernous hemangioma. 1.5 cm3 of 1 % STS
was injected into the lesion two times. When the first
injection was administered, the patient complained about
pain and burning sensation on the right buccal area. After
3 weeks of the first procedure, the size of the lesion
decreased to 2 × 1.5 × 0.3 cm. After the second procedure
was carried out, the size of the lesion had not altered yet
the thickness was reduced. After 2 months of the second
procedure, 1.5 cm3 of 1 % STS was injected to the
remaining lesion. Comparing from the first visit, the size
of the lesion was regressed to 0.5-cm nodule (Fig. 1b).Case 2
A 69-year-old woman with bluish circular lesion on the
lower lip visited the department. The patient had neither
history of pain nor ulceration on the area. A localized
dome-shaped swelling was detected in the midline of
the lower lip. The patient did not complain any pain
on palpation, and the size was approximately 0.6 ×
0.6 × 0.1 cm (Fig. 2a). The patient has recognized the
lesion for about 15 years and had no plan to visit the
clinics since the lesion had no symptoms. Based on the
clinical finding, provisional diagnosis was venous malfor-
mation. 0.2 cm3 of 1 % STS was injected, and after a
week, the lesions faded and the color became similar
to adjacent tissue (Fig. 2b).Fig. 1 a Cavernous hemangioma on the right buccal mucosa. b Three-moCase 3
A 62-year-old female with chief complain of a bluish
dome-shaped swelling on the left upper lip visited the
department. The patient has recognized the lesion for
about 4 years. The patient had neither history of pain
nor ulceration. Border of the lesion was well defined and
the size was approximately 0.8 × 0.8 × 0.3 cm (Fig. 3a).
The patient was clinically diagnosed with venous malfor-
mation. By using sclerotherapy, 1.0 cm3 of 1 % STS was
given at the site. Regression of intraoral venous malfor-
mation was observed after 3 weeks. The affected sites
almost healed and got flatten (Fig. 3b).
Discussion
Hemangioma is a benign neoplasm which blood vessels
grow abnormally. Hemangioma, according to the depth
of the lesion, is classified as superficial (i.e., capillary),
deep (i.e., cavernous), and compound (i.e., capillary
cavernous) hemangioma [2]. Histologically, hemangioma
is the proliferation of endothelial cells that can manifest at
any parts of the body and appears mostly in the head and
neck area [4, 9]. Intraoral hemangioma appears in the
head and neck area unfrequently, but oral mucosa and skin
are the most affected tissues in the oral cavity followed by
the surrounding bone and muscle. Hemangioma is charac-
terized by three stages: (a) proliferating, (b) involuting
phase, and (c) involuted phase. Proliferating phase (an age
of 0–1 year) exhibits characteristics of rapid growth and
multi-laminated basement membrane under endothelium.
In involuting phase (an age of 1–5 years), on the other
hand, proliferation of endothelial cells and apoptosis
increase. Involuted phase (an age over 5 years) indicates
the complete regression of lesion and is featured by
histological fibrosis and fat deposition [10].
Vascular malformations are benign lesions which are
caused by structural anomalies of vessels. Like hemangioma,
these lesions can arise anywhere in the body and can be
found at birth, in infancy, and in adulthood. Most commonly
affected intraoral tissues are anterior two thirds of the
tongues, palate, gingiva, and buccal mucosa. Vascular
malformations can be categorized as low-flow (i.e., capil-
lary, venous, lymphatic), high-flow (i.e., arterial), and com-
bination lesions (i.e., arteriovenous, lymphatico-venous,nth postoperative appearance
Fig. 2 a Localized dome-shaped swelling in the midline of the lower lip. b After a week, the color became similar to adjacent tissue
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histologically, they do not reveal endothelial proliferation
and do not multiply or regress throughout life [10].
The diagnosis of these benign vascular lesions requires
clinical examination, biopsy, sonography, computed tom-
ography (CT), magnetic resonance imaging (MRI), and
angiography. The goals of treatment are as follows:
1. Prevent the complications that affect the patient’s
well-being.
2. Not to cause permanent physical deformities.
3. Reduce the stress of patients and family from
esthetic problems.
4. Better to avoid treatments which leave scars.
5. To reduce infection and pain, ulcer should be
treated appropriately [6].
Treatment options for small and peripheral vascular
lesions are conventional surgical excision, laser therapy,
cryotherapy, selective embolization, sclerotherapy, and
medical treatment using beta blocker or steroid.
When the lesions are larger and deeper, embolization
or obliteration to adjacent vessel is required. These treat-
ments lead to irreversible tissue injury and gradual fibro-
sis. Currently, surgical resection is considered as the
best treatment for vascular benign lesions which occurred
in the head and neck. Surgical resection should be per-
formed to prevent recurrence. However, surgical resection
is limited when complete resection is not possible,
when it may cause critical bleeding problem or whenFig. 3 a Well-defined border and dome-shaped swelling on the left up
b After 3 weeks later, the affected site almost healedcrucial organs can be injured. Extensive surgery in the oral
cavity can induce a problem of chewing or swallowing.
For lesions that are small or located where esthetical
conservation is required, sclerotherapy can be an alter-
native to surgical treatment [7]. Sclerotherapy can regress
lesions partially or entirely and is effective for relieving
symptoms. Furthermore, the procedure is simple, less
invasive, and inexpensive. By using sclerotherapy, it is
possible to receive treatment as an outpatient [3, 4]. How-
ever, sclerotherapy should be performed with care, because
it can cause complications such as pulmonary embolism,
anaphylaxis, nerve damage, increased pain, and dissemi-
nated intravascular coagulation [3].
For sclerotherapy, ethanol, sodium morrhuate, STS,
and bleomycin can be used. STS is a sclerosant which
has been used widely for the treatment of low-flow
vascular lesion since 1940s. This acts on a lipid molecule
of endothelial cells and induces surface injury and collagen
exposure, causing inflammatory reaction and organization
of thrombus [8]. As a result, injected vein undergo fibro-
sis, the vessel lumen obliterate partially or completely, and
the lesions regress [3, 4, 9]. STS should be injected mini-
mally at interval of 5–7 days between each injections [5].
Kim et al. reported three cases that were treated by
injecting 1 or 3 % STS in benign oral vascular lesions
[11]. They injected 2 mL of 3 % STS in the hemangioma
of the lower labial mucosa, 2 mL of 1 % STS in the
hemangioma of the right buccal mucosa, and 2 mL of
3 % STS in the venous malformation of the palate.
The result of treatments was satisfied esthetically andper lip. The patient was diagnosed with venous malformation.
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treated by injecting 1 % STS in the venous malforma-
tion of the tongue and left buccal mucosa [5]. After
the injection, the lesions were regressed remarkably.
Alakailly et al. reported 13 cases that were treated by
injecting 3 % STS in the venous malformation of the
head and neck [12]. They injected a minimum of
0.5–2 mL into each lesion. The volume was depending
on a ratio of 0.5 mL for each 2 cm of lesion size or a
quarter volume of the lesion. Four patients had complete,
five patients had 75 %, two patients had 50 %, and one
patient had 25 % shrinkage of the lesion size. But, one
patient had no response. After the injection, two patients
had a superficial ulceration which healed without leaving
scar. One patient had mild ecchymosis.
Same for other sclerosing agent, STS occasionally can
cause pain, ulceration, edema, cardiovascular collapsing,
and anaphylaxis [8]. In these cases, to reduce the side
effects, 1 % STS was injected into the lesions instead of
3 % STS. In all cases, the size of lesions was remarkably
regressed without complications after the injection.
Because the reactions to sclerosant agent are different for
each patient, there is no clear guideline for the standard
therapeutic dose of STS for the treatment of benign oral
vascular lesions. According to the manufacturer’s instruc-
tions, 0.5–2.0 mL of 3 % STS can possibly inject into a
lesion per one dose and it must not be administered over
2 mL into the lesion.Conclusions
STS is effective in treating benign vascular lesions of
small size in oral cavity. Advantages of STS are that it is
inexpensive and it makes possibility to avoid the risk of
surgery. However, as it is not the definitive treatment
that can completely remove the lesion, it is effective
when the size of lesion is small, and the growth of lesion
is slow. Therefore, in order to use STS, patient selection
and evaluation of patient is important and thorough
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